Fundz

Viatris Inc. Completes Acquisition of Pacira BioSciences, Inc.

PUBLIC · VTRSNov 17, 2026

Acquiring Company

Viatris

Acquired Company

Capra Biosciences, Inc

CanonsburgAlexandriaBiotechnologyHealth CareMedical Device

Description

On November 17, 2026, Viatris Inc. completed its acquisition of Pacira BioSciences, Inc. through a merger agreement. A total of 32,929,780 shares of Pacira were validly tendered in the associated tender offer. The merger allows Pacira to continue as a wholly owned subsidiary of Viatris, enhancing Viatris' capabilities in the healthcare market.

Quick answer

Viatris is acquiring Capra Biosciences, Inc, announced November 17, 2026. Viatris is based in Canonsburg, Pennsylvania, United States.

How much did Viatris pay for Capra Biosciences, Inc?
The deal value was not disclosed.
What does Viatris do?
Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania.
Where are Viatris and Capra Biosciences, Inc based?
Viatris is based in Canonsburg, Pennsylvania, United States. Capra Biosciences, Inc is based in Alexandria, Virginia, United States.

Source: Fundz verified event record.

Other recent acquisitions in Medical Device and Biotechnology

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Viatris, and when

When Viatris changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Viatris raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Viatris, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Viatris. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Viatris

Location

Canonsburg, Pennsylvania, United States

About

Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania. Formed in November 2020 from the merger of Mylan and Pfizer's Upjohn division, Viatris aims to enhance access to medicines worldwide. The company operates in over 165 countries and territories, delivering high-quality medicines to patients. Viatris offers a diverse portfolio that includes generics, established brands, biosimilars, and innovative specialty medicines. Their product range encompasses oral solid doses, injectables, complex dosage forms, and active pharmaceutical ingredients. The company addresses various therapeutic areas, such as cardiovascular health, oncology, infectious diseases, and women's healthcare. In addition to its products, Viatris provides support services like diagnostic clinics and educational seminars to help patients manage their health effectively. With a workforce of around 45,000 employees, Viatris serves a wide array of customers, including hospitals, clinics, and pharmacies, across multiple market segments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Viatris makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Viatris's next move

Learn about Strategic plan

Frequently asked

Who acquired Capra Biosciences, Inc?

Capra Biosciences, Inc was acquired by Viatris, based in Canonsburg. The deal was reported on November 17, 2026. Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania. Viatris is publicly traded (VTRS).

When did Viatris acquire Capra Biosciences, Inc?

Viatris's acquisition of Capra Biosciences, Inc was reported on November 17, 2026. On November 17, 2026, Viatris Inc. completed its acquisition of Pacira BioSciences, Inc. through a merger agreement. A total of 32,929,780 shares of Pacira were validly tendered in the associated tender offer. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Capra Biosciences, Inc do?

Pacira CryoTech, Inc. is a wholly owned subsidiary of Pacira Biosciences, Inc. that specializes in handheld cryoanalgesia devices and related products. The company is known for its flagship device, iovera®°, which provides non-opioid pain management solutions. It is privately held, operating in Biotechnology, and is based in Alexandria.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.